DAVID RIOUX: Open Payments
NPI 1316084650 · MACHIAS, ME. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,336 in 67 payments from 19 companies in 2025. Trend: 2023 $1,273 · 2024 $1,581 · 2025 $1,336
Food & beverage: $1,336
| Company | Payments | Amount |
|---|---|---|
| Lundbeck LLC | 12 | $258 |
| PFIZER INC. | 14 | $215 |
| Novo Nordisk Inc | 6 | $119 |
| Exact Sciences Corporation | 5 | $111 |
| Merck Sharp & Dohme LLC | 5 | $99 |
| AstraZeneca Pharmaceuticals LP | 4 | $85 |
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 3 | $65 |
| Boehringer Ingelheim Pharmaceuticals, Inc. | 3 | $61 |
| ABBVIE INC. | 2 | $55 |
| GlaxoSmithKline, LLC. | 3 | $49 |
Products named: REXULTI, ELIQUIS, NURTEC ODT, The Cologuard Plus Collection Kit, CAPLYTA, JARDIANCE, VERQUVO, PAXLOVID.
Industry payments across ME — which companies pay providers there.
